Valuation : InterCure Ltd.

Market Cap 194M 0 167M 157M 143M 268M 18.45B 269M 1.86B 720M 9.4B 728M 712M 29.78B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 330M 0 284M 268M 244M 456M 31.43B 458M 3.17B 1.23B 16.01B 1.24B 1.21B 50.72B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day-2.79%
1 week-2.79%
Current month-8.75%
1 month+10.65%
3 months+15.53%
6 months+26.36%
Current year+1.17%
1 week 1,617
Extreme 1617
1,702
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Other

Chief Financial Officer

539,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-2.79%-2.79%-40.17%-48.21% 64.04M
-1.98%+2.77%+14.23%+226.37% 363M
0.00%-7.27%-32.89%-27.83% 156M
-1.51%-1.51%+12.64%+94.06% 140M
0.00%+9.09%-35.14%-58.26% 97.54M
Average -1.26%+0.06%-16.26%+37.23% 164.17M
Weighted average by Cap. -1.35%+0.45%-5.10%+100.25%

Financials

2024 2025
Net sales 239M 0 206M 194M 176M 330M 22.73B 331M 2.29B 886M 11.58B 897M 877M 36.68B 270M 0 233M 219M 199M 373M 25.71B 375M 2.59B 1B 13.1B 1.01B 993M 41.5B
Net income -67.8M -0 -58.34M -54.93M -50.05M -93.65M -6.45B -94.02M -651M -252M -3.29B -255M -249M -10.41B -35.71M -0 -30.73M -28.93M -26.36M -49.33M -3.4B -49.52M -343M -133M -1.73B -134M -131M -5.48B
Net Debt 133M 0 114M 108M 98.01M 183M 12.63B 184M 1.27B 493M 6.44B 498M 488M 20.39B 136M 0 117M 110M 101M 188M 12.97B 189M 1.31B 506M 6.61B 512M 501M 20.94B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
10/09/26 ILA 1,603.00 -2.08% 101
09/09/26 ILA 1,637.00 -2.79% 8,278
08/09/26 ILA 1,684.00 +0.90% 6,257
07/09/26 ILA 1,669.00 +0.42% 12,751
04/09/26 ILA 1,662.00 +2.47% 5,273
  1. Stock Market
  2. Stocks
  3. INCR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!